Menu

利伐沙班作用与功效,利伐沙班2021多少钱一盒?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Function and efficacy: Rivaroxaban is a highly selective, oral drug that directly inhibits factor Xa. By highly selectively and competitively inhibiting free and bound factor Rivaroxaban does not inhibit thrombin (activated factor II) and has no proven effect on platelets. The essential difference between rivaroxaban and fondaparinux sodium/heparin is that it does not require the participation of antithrombin III and can directly antagonize free and bound factor Xa; while heparin requires antithrombin III to work and is ineffective against factor Xa in the prothrombin complex.

Indications for Rivaroxaban:

1. For adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).

2. Used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT.

3. For use in adult patients with non-valvular atrial fibrillation who have one or more risk factors (such as congestive heart failure, hypertension, age ≥75 years, diabetes, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism.

:

According to Medical Companion Travel, there are two specifications of rivaroxaban produced by Bayer in Germany: Rivaroxaban of 20mg*28 tablets/box, priced at around $400; the other is rivaroxaban of 15mg*28 tablets/box, priced at less than 400$. Due to the floating exchange rate, the price is different. Please contact Medical Companion Travel for the specific price!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related hot articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。